Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Poliglumex, Carboplatin, and Radiation in Stage III NSCLC
NCT00352690Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2006
- Primary completion
- Jun 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in non-small cell lung cancer (NSCLC), sponsored by Washington University School of Medicine. Started Apr 2006; status: terminated.
02
Drugs
paclitaxel poliglumex
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00352690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352690.